Start for free
Start for free
Maxim Group logo

Maxim Group

North America, New York, United States, New York

Description

Maxim Group is a full-service firm that offers investment banking, and securities and wealth management services.

Investor Profile

Maxim Group has made 7 investments, with 0 in the past 12 months and 57% as lead.

Stage Focus

  • Post Ipo Equity (29%)
  • Series Unknown (29%)
  • Series A (14%)
  • Series C (14%)
  • Series B (14%)

Country Focus

  • United States (86%)
  • Israel (14%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Genetics
  • Manufacturing
  • 3d Printing
  • Alternative Protein
  • Food Processing
  • Machinery Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Maxim Group frequently co-invest with?

Jefferies
Jefferies
North America, New York, United States, New York
Co-Investments: 1
Civilization Ventures
Civilization Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Retinal Degeneration Fund
Retinal Degeneration Fund
North America, North Carolina, United States, Raleigh
Co-Investments: 1
H. C. Wainwright & Co.
H. C. Wainwright & Co.
North America, New York, United States, New York
Co-Investments: 1
FBR & Co
FBR & Co
North America, Virginia, United States, Arlington
Co-Investments: 1
RBC Capital Markets
RBC Capital Markets
North America, New York, United States, Albany
Co-Investments: 1
Cantor Fitzgerald
Cantor Fitzgerald
North America, New York, United States, New York
Co-Investments: 1
Foundation Fighting Blindness
Foundation Fighting Blindness
North America, Maryland, United States, Columbia
Co-Investments: 1
Celesta Capital
Celesta Capital
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by Maxim Group?

Steakholder Foods

Rehovot, HaMerkaz, Israel

Steakholder Foods is a leading innovator in alternative proteins production and 3D printing production technologies.

3D PrintingAlternative ProteinBiotechnologyFood ProcessingMachinery Manufacturing
Post Ipo EquityJan 6, 2023
Amount Raised: $6,500,000
Nacuity Pharmaceuticals

Fort Worth, Texas, United States

Nacuity Pharmaceuticals is a pharmaceutical company that aims to develop a breakthrough treatment for retinitis pigmentosa.

Health CarePharmaceutical
Series BJun 15, 2022
Amount Raised: $16,500,000
Alveo Technologies

Alameda, California, United States

Alveo is a pre-clinical stage medical diagnostics company .

Health CareMedicalMedical Device
Series AJan 5, 2018
Amount Raised: $38,000,000
Abeona Therapeutics

New York, New York, United States

Abeona Therapeutics develops gene therapy-based potential cures for Sanfilippo syndrome types A and B.

BiotechnologyGeneticsHealth CareManufacturingMedical Device
Post Ipo EquityOct 19, 2017
Amount Raised: $92,000,000
Edge Therapeutics

Berkeley Heights, New Jersey, United States

Edge Therapeutics, a biotechnology company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions.

BiotechnologyHealth CareMedical
Series CJun 4, 2013
Amount Raised: $18,000,000
ContraFect

Yonkers, New York, United States

ContraFect is a biotechnology company researching the use of monoclonal antibodies to treat life-threatening infectious diseases.

BiotechnologyHealth CareMedical
Series UnknownSep 15, 2011
Amount Raised: $12,502,905
BillMyParents

San Diego, California, United States

BillMyParents is a shopping system for children to purchase using their parents’ credentials via an email request and approval system.

E-CommerceFinancial ServicesParentingTeenagersYoung Adults
Series UnknownNov 24, 2010
Amount Raised: $3,400,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator